Sunshine Biopharma (SBFMW) EBT Margin (2018 - 2025)
Historic EBT Margin for Sunshine Biopharma (SBFMW) over the last 9 years, with Q3 2025 value amounting to 10.84%.
- Sunshine Biopharma's EBT Margin rose 8000.0% to 10.84% in Q3 2025 from the same period last year, while for Sep 2025 it was 17.44%, marking a year-over-year decrease of 49600.0%. This contributed to the annual value of 15.4% for FY2024, which is 16700.0% up from last year.
- As of Q3 2025, Sunshine Biopharma's EBT Margin stood at 10.84%, which was up 8000.0% from 21.04% recorded in Q2 2025.
- In the past 5 years, Sunshine Biopharma's EBT Margin ranged from a high of 783.75% in Q4 2021 and a low of 15440.43% during Q1 2021
- In the last 5 years, Sunshine Biopharma's EBT Margin had a median value of 21.04% in 2025 and averaged 1650.19%.
- Per our database at Business Quant, Sunshine Biopharma's EBT Margin tumbled by -145914000bps in 2021 and then soared by 144324500bps in 2022.
- Sunshine Biopharma's EBT Margin (Quarter) stood at 783.75% in 2021, then tumbled by -175bps to 590.86% in 2022, then surged by 98bps to 13.41% in 2023, then crashed by -78bps to 23.83% in 2024, then soared by 55bps to 10.84% in 2025.
- Its last three reported values are 10.84% in Q3 2025, 21.04% for Q2 2025, and 13.71% during Q1 2025.